Overview / Abstract: |
In this fast-moving, 1-hour accredited activity, Craig Kessler, MD, and Guy Young, MD, share their thoughts and experience with clotting factor concentrates, recombinant factor, factor VIII mimetics, rebalancing agents, and gene therapies. The safety and efficacy of late-phase investigational products are also discussed as these agents have the potential to address unmet needs and further transform patient care. |
Expiration |
Sep 27, 2025 |
Discipline(s) |
Nurse Practitioner , Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Craig M. Kessler, MD Guy Young, MD |
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent educational grant from Novo Nordisk. |
Keywords / Search Terms |
Annenberg Center for Health Sciences at Eisenhower Epidemiology and burden of disease, Clotting factor concentrates, Recombinant factor, Factor VIII mimetics, Rebalancing agents Gene therapies Free CE CME |